NASHUA, N.H., Nov. 13, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered breast health ...
iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered solutions that enable medical providers to accurately and ...
ICAD Inc ICAD is poised to benefit in the long term from its AI-driven cancer detection tools and electronic brachytherapy product, according to BTIG. The iCAD Analyst: Marie Thibault initiated ...
Groundbreaking ProFound AI Risk Helps Transform Breast Cancer Screening from an Age-Based Paradigm to Risk-Adapted Precision Screening, Individualized for Each Woman NASHUA, N.H., Nov. 30, 2020 (GLOBE ...
Icad Inc ICAD shares are trading higher Monday after the company announced a strategic development and commercialization agreement with Alphabet Inc's GOOG Google Health. The agreement will allow ...
AI applications streamline workflow and support clinicians in delivering more personalized breast care, including cancer detection, density assessment, and recommendations NASHUA, N.H., Nov. 28, 2023 ...
iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can't hide by providing clinically proven AI-powered solutions that enable medical providers to accurately and ...
(MENAFN- GlobeNewsWire - Nasdaq) NASHUA, N.H., July 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the“Company”), a global leader in clinically proven AI-powered cancer detection ...
RadNet, Inc. has announced its acquisition of iCAD, Inc. in an all-stock transaction valued at approximately $103 million. This merger aims to enhance RadNet's existing AI-powered cancer detection ...
NASHUA, N.H., Aug. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc (ICAD). (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it ...
NASHUA, N.H., April 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically ...
iCAD to Present at the Spring Into Action - Best Ideas Virtual Investor Conference on May 17th, 2022
NASHUA, NH / ACCESSWIRE / May 12, 2022 /iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results